Bildkälla: Stockfoto

Active Biotech Q4 2023: Three Externally Funded Trials in 2024 - Redeye

Redeye provides its view of Active Biotech's fourth quarter report of 2023 and updates it base case.

Redeye provides its view of Active Biotech's fourth quarter report of 2023 and updates it base case.
Börsvärldens nyhetsbrev
ANNONSER